论文部分内容阅读
流行病学每年新增病例95.2万,死亡病例72.3万.亚洲胃癌发病率及死亡率居全世界首位.晚期胃癌的化疗进展(1)转移性弥漫型胃腺癌化疗:SP方案优于FP方案?S-1+顺铂对比5-FU+顺铂一线治疗转移性弥漫型胃腺癌的随机Ⅲ期临床研究(DIGEST研究)
晚期胃癌治疗进展
【摘 要】
：
流行病学每年新增病例95.2万,死亡病例72.3万.亚洲胃癌发病率及死亡率居全世界首位.晚期胃癌的化疗进展(1)转移性弥漫型胃腺癌化疗:SP方案优于FP方案?S-1+顺铂对比5-FU+顺铂
【机 构】
：
江苏省肿瘤医院
【出 处】
：
华东抗肿瘤药物研究新进展与肿瘤精准治疗论坛
【发表日期】
：
2015年10期
其他文献
Objectives: The aim of this study is to explore the Keap1-Nrf2 balance in tumor proliferation,drug resistance and invasion,by using the Keap1-overexpressing
目的：阿霉素作为治疗骨肉瘤的一线化疗药物，仍因复发和转移的出现而宣告治疗失败。根据肿瘤干细胞理论，骨肉瘤干细胞的存在可能是治疗失败的关键因素，目前针对骨肉瘤化疗与肿
Background: The aim of our study is to evaluate the preliminary efficacy and side effects of paclitaxel,5-fluorouracil and leucovorin intravenous chemothera
会议
Objectives: Unimolecular micelles were prepared by modification of polyamidoamine(PAMAM)dendrimersusing pluronic F68(PF68),which is expected to reverse mult
Objective: Most non-small cell lung cancer(NSCLC)patients responding to gefitinib harbor activating mu tations in the epidermal growth factor receptor(EGFR)
会议
Background: Gastric cancer is the fourth most common cancer in the world.The development of both chemotherapy and targeted drugs are limited due to the comp
会议
Background: β-elemene is a novel anticancer drug extracted from herb which has been used to target various solid tumours and Hyperthermia is an adjuvant th
会议
Objective: Anti-PD-1/PD-L1 antibodies showed satisfactory efficacy in treating non-small-cell lung cancer.We conducted this meta-analysis to explore the adv
会议